← back to search

Matteo Rocchetti

University of Pavia · IT
Area of research
Psychiatry and Mental health · Philosophy
Research interest
Research interests include Schizophrenia research and treatment, Mental Health and Psychiatry, Autism Spectrum Disorder Research, and Mental Health Research Topics.
h-index
27
citations
3,568
works
85
NIH funding
primary concept
email

Recent publications

Sex differences in schizophrenia spectrum disorders: insights from the DiAPAson study using a data-driven approach
Social Psychiatry and Psychiatric Epidemiology 2025cited by 8position: middledoi
Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study
Frontiers in Psychiatry 2022cited by 7position: middledoi
What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials
Autism 2019cited by 70position: middledoi
Semistructured Interview for Bipolar At Risk States (SIBARS)
Psychiatry Research 2018cited by 59position: middledoi
Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis
Schizophrenia Bulletin 2017cited by 33position: middledoi
Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis
Journal of Affective Disorders 2016cited by 144position: middledoi
Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation
Schizophrenia Bulletin 2016cited by 129position: middledoi
Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS
Psychiatry Journal 2016cited by 122position: middledoi
Why are help-seeking subjects at ultra-high risk for psychosis help-seeking?
Psychiatry Research 2015cited by 135position: middledoi
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Schizophrenia Bulletin 2014cited by 692position: middledoi
Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study
Psychological Medicine 2014cited by 71position: middledoi
Is cannabis neurotoxic for the healthy brain? A meta‐analytical review of structural brain alterations in non‐psychotic users
Psychiatry and Clinical Neurosciences 2013cited by 104position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Paolo Fusar‐Poli · King's College London9 papers (2013–2018)Philip McGuire · McGill University8 papers (2014–2018)Marco Cappucciati · Substance Abuse and Mental Health Services Administration5 papers (2016–2018)Grazia Rutigliano · King's College London5 papers (2016–2018)Ilaria Bonoldi · King's College London3 papers (2016–2018)Marianna Frascarelli · Unitelma Sapienza University3 papers (2014–2016)Andrea De Micheli · King's College London3 papers (2016–2018) · 3 papers (2013–2019)Stefania Tognin · South London and Maudsley NHS Foundation Trust2 papers (2014–2016)Rashmi Patel · University of Cambridge2 papers (2016–2017)Steven Badger · King's College London2 papers (2015–2016)Ceri Jones · King's College London2 papers (2015–2016)Irina Falkenberg · Universitätsklinikum Gießen und Marburg2 papers (2015–2018)Stefan Borgwardt · Authorised Association Consortium2 papers (2013–2016)Daniel Ståhl · King's College London2 papers (2014–2014)Valentina Ramella‐Cravaro · King's College London2 papers (2017–2018) · 1 papers (2016–2016)Paola Landi · King's College London1 papers (2016–2016) · 1 papers (2016–2016)Majella Byrne · King's College London1 papers (2014–2014)